Kentucky governor, Matt Bevin, recently signed HB 78 into law, requiring Kentucky mammography providers to report dense breast tissue to patients through the mammogram report. The law will become effective in July of 2017.
Topics: Legal and Regulatory
On March 15, 2017, the FDA issued a drug safety warning that Viberzi (eluxadoline), a drug used to treat irritable bowel syndrome with diarrhea (IBS-D), should not be used in patients who do not have a gallbladder. The FDA found that when used in patients without a gallbladder there is an increased risk of developing serious pancreatitis that could result in hospitalization or death. Patients who are taking Viberzi (eluxadoline) who do not have a gallbladder should stop taking the drug immediately and contact their physician.
Topics: Patient Safety